Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Feb 11, 2026
Reporting period
Not applicable
Filed with the SEC
Feb 13, 2026
CEOTax withholding
Context
Classification
tax withholding
Code F — shares delivered to pay exercise price or tax liability
Planned / mechanical clue
Tax mechanics (code F)
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001682852-26-000017
Filed / recorded
Feb 13, 2026, 9:23 PM UTC
Added to OQRO
Oct 2, 2026, 12:28 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
Moderna, Inc.
Issuer CIK
1682852
Ticker
MRNA
Reporting person
Stephane Bancel
Relationship
Director, Officer
Officer title
Chief Executive Officer
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
Feb 11, 2026
Transaction code
F
Shares / units
5,450
Price per share
$41.99
Acquired / disposed
Disposed (D)
Shares owned after
6,187,791
Ownership form
Direct
Amendment
No
Footnotes from the filing
Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vesting of the 2023 PSUs.